In 2020, the Legislature directed health plans, beginning January 1, 2021, to limit an enrollee's out-of-pocket expenses for insulin to $100 for a 30-day supply. The out-of-pocket limit is set to expire on January 1, 2023.
Also in 2020, the Legislature established the Total Cost of Insulin Work Group (work group) within the Health Care Authority. The work group was directed to review and design strategies to reduce the cost of total expenditures on insulin in this state. Strategies the work group must consider include, but are not limited to:
Beginning January 1, 2023, health plans must cap the total amount an enrollee is required to pay for a covered insulin drug at an amount not to exceed $35 per 30-day supply. This limit expires on January 1, 2024.
The work group must design strategies to provide a once yearly 30-day supply of insulin to individuals on an emergency basis. The strategies identified by the work group must include recommendations on eligibility criteria, patient access, program monitoring, and pharmacy reimbursement.
The due dates for work group reports are extended to December 1, 2022, for its preliminary report, and July 1, 2023, for its final report.